Advertisement

<a href="//cdm-d.openx.net/w/1.0/rc?cs=ede153ebee&cb=INSERT_RANDOM_NUMBER_HERE"> <img src="//cdm-d.openx.net/w/1.0/ai?auid=538187993&cs=ede153ebee&cb=INSERT_RANDOM_NUMBER_HERE" border="0" alt=""></a>

#Descovy

The FDA approved Truvada for use as HIV prevention on July 16, 2012.

As PrEP Turns Five, the HIV Prevention Pill Is a Major Success

The science behind Truvada as pre-exposure prophylaxis reveals an awesome tool that is apparently already helping shrink U.S. HIV rates.

Gilead Files For FDA Approval of Integrase Inhibitor–Based HIV Regimen

The single-tablet regimen includes the experimental bictegravir plus the contents of Descovy (emtricitabine/tenofovir alafenamide).

Prevention: New PrEP Trial

New trial compares Descovy to Truvada.

Descovy

FDA OKs Gilead’s Descovy (Not for PrEP)

The U.S. Food and Drug Administration approved Gilead Sciences’ Descovy for the treatment of HIV in combination with other antiretrovirals.

FDA OKs Gilead’s Descovy, a Safer Version of Truvada, for HIV Treatment Only (Not for PrEP)

The FDA has approved Gilead Sciences’ fixed-dose combination tablet Descovy (emtricitabine/tenofovir alafenamide) for HIV treatment.

Advertisement

<a href="//cdm-d.openx.net/w/1.0/rc?cs=ede153ebee&cb=INSERT_RANDOM_NUMBER_HERE"> <img src="//cdm-d.openx.net/w/1.0/ai?auid=538187994&cs=ede153ebee&cb=INSERT_RANDOM_NUMBER_HERE" border="0" alt=""></a>